Veraxa Biotech Holding AG (VRXA) Accounts Payables (2024 - 2025)

Veraxa Biotech Holding AG (VRXA) has reported Accounts Payables for 2 consecutive years, with $1.7 million the latest figure, recorded in Q4 2025.

• For the quarter ending Q4 2025, Accounts Payables rose 212.06% year-over-year to $1.7 million; the trailing twelve-month figure through Dec 2025 stood at $1.7 million (up 212.06% YoY), and the FY2025 full-year result was $1.7 million, up 212.06% from the prior year.
• Accounts Payables grew to $1.7 million in Q4 2025 per VRXA's latest filing, from $557682.5 in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $1.7 million in Q4 2025 to a low of $557682.5 in Q4 2024.